Quantitative autoradiography of cocaine binding sites in human brain postmortem
โ Scribed by Anat Biegon; Kathryn Dillon; Nora D. Volkow; Robert J. Hitzemann; Joanna S. Fowler; Alfred P. Wolf
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 607 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0887-4476
No coin nor oath required. For personal study only.
โฆ Synopsis
Quantitative autoradiography was used to study cocaine binding sites in the human brain postmortem. Tritiated cocaine was applied to brain sections from three drug-and disease-free subjects at a low (10 nM) concentration and at a high (1 pM) concentration, the latter being in the range of brain concentrations of cocaine found in users of the drug. Nonspecific binding was assessed in the presence of 100 pM unlabeled cocaine. At low (10 nM) concentrations of labeled cocaine, the basal ganglia exhibit the highest density of binding sites, with considerably lower densities in thalamus, cortex, and hippocampus. Cocaine binding at high (1 pM) concentrations displayed a different distribution pattern, more homogeneous with some cortical regions exhibiting binding site densities close to those seen in the basal ganglia. Preliminary competition experiments with several drugs indicate that dopamine uptake inhibitors completely block cocaine binding to the basal ganglia, while serotonin uptake inhibitors were more effective in the hippocampus. These findings suggest that cocaine binds to dopamine uptake sites in the human basal ganglia postmortem but that it also interacts with other classes of binding sites, depending on the concentration and brain region examined.
๐ SIMILAR VOLUMES
The first direct measurements of cocaine binding in the brain of normal human volunteers and baboons have been made by using positron emission tomography (PET) and tracer doses of [N-llC-methyll-( -)-cocaine ([ "Clcocaine). Cocaine's binding and release from brain are rapid with the highest regional
High-affinity, specific 3H-5-hydroxytryptamine (5-HT) binding was analyzed in membrane homogenates of human frontal cortex, caudate, and globus pallidus. 5-HT1A and 5-HT1C binding sites were pharmacologically blocked using 100 nM 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT) and 100 nM mesulerg